Boston Globe -- Drug maker Shire Pharmaceuticals is buying four buildings in Raytheon’s former Lexington campus along Route 2 for more than $200 million, marking a major move forward for the recovering commercial real estate market.
Boston Globe -- Drug maker Shire Pharmaceuticals is buying four buildings in Raytheon’s former Lexington campus along Route 2 for more than $200 million, marking a major move forward for the recovering commercial real estate market.
